Pharmacokinetic and Statistical Considerations in First-in-Human Clinical Trials | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services
Database of pharmacokinetic time-series data and parameters for 144 environmental chemicals | Scientific Data
Modelling and simulation in drug development, promise and reality – Drug Discovery World (DDW)
Sample phase 0/2 clinical trial study design for brain tumors. Patients... | Download Scientific Diagram
Dose rationale and pharmacokinetics of dexmedetomidine in mechanically ventilated new-borns: impact of design optimisation | SpringerLink
Clinical Sample Management | Precision for Medicine
Guidelines for the experimental design of pharmacokinetic studies with nanomaterials in preclinical animal models - ScienceDirect
Pharmaceutics | Free Full-Text | Pharmacokinetic-Pharmacodynamic Modelling of Systemic IL13 Blockade by Monoclonal Antibody Therapy: A Free Assay Disguised as Total | HTML
PDF) Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE study | Margaret Kirshner - Academia.edu
Research Phases | NMS Labs
Phase 0 clinical trials in oncology new drug development Gupta UC, Bhatia S, Garg A, Sharma A, Choudhary V - Perspect Clin Res
Pharmacokinetic–pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies | British Journal of Cancer
The importance of clinical pharmacokinetic–pharmacodynamic studies in unraveling the determinants of early and late tuberculosis outcomes | International Journal of Pharmacokinetics
PK Clinical Trial During New Drug Discovery and Development – An Overview by mariabrownema - Issuu
PK_PD-Sample-Management - Clinical trials and CRO centric systems
Pharmacodynamic Biomarker Testing - Almac
Impact of Sample Handling and Processing on Bioanalycial Outcome
What is a PP Population, or 'Per Protocol' Population in a Clinical Trial? - Quantics Biostatistics
Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial - The Lancet HIV
Improving the Accuracy of Predicted Human Pharmacokinetics: Lessons Learned from the AstraZeneca Drug Pipeline Over Two Decades: Trends in Pharmacological Sciences
Gina McMullen Sr. PK Research Associate ISIS Pharmaceuticals, Inc. - ppt download
Phase 1 clinical trial schema. Abbreviations: E = enrollment, qwk = per... | Download Scientific Diagram
Pharmacokinetic and Statistical Considerations in First-in-Human Clinical Trials | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services
Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives - ScienceDirect
